Veru

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Veru and other ETFs, options, and stocks.

About VERU

Veru, Inc. is a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of metabolic diseases, oncology, and ARDS. The company’s drug development program includes two late-stage novel small molecules, enobosarm and sabizabulin.

CEO

Mitchell Shuster Steiner

CEOMitchell Shuster Steiner

Employees

—

Employees—

Headquarters

Miami, Florida

HeadquartersMiami, Florida

Founded

1971

Founded1971

Employees

—

Employees—

VERU Key Statistics

Market cap

208.59M

Market cap208.59M

Price-Earnings ratio

-1.79

Price-Earnings ratio-1.79

Dividend yield

—

Dividend yield—

Average volume

2.71M

Average volume2.71M

High today

$1.46

High today$1.46

Low today

$1.35

Low today$1.35

Open price

$1.38

Open price$1.38

Volume

1.54M

Volume1.54M

52 Week high

$1.92

52 Week high$1.92

52 Week low

$0.36

52 Week low$0.36

VERU News

Yahoo Finance 4h

Veru to Report Fiscal 2024 Second Quarter Financial Results on May 8, 2024 - Yahoo Finance

Veru Inc. MIAMI, FL, May 01, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovativ...

Yahoo Finance 1d

Veru Inc. Just Flashed Golden Cross Signal: Do You Buy? - Yahoo Finance

Veru Inc. (VERU) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, VERU's 50-day simple...

TipRanks 1d

Veru enrolls first patients in Phase 2b trial of enobosarm, semaglutide

Veru announced that it has enrolled the first patients in its Phase 2b clinical trial of enobosarm, an oral selective androgen receptor modulator, SARM, to avoi...